These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 2502552)

  • 21. Induction of hypothyroidism and hypoprolactinemia by growth hormone producing rat pituitary tumors.
    Seo H; Refetoff S; Fang VS
    Endocrinology; 1977 Jan; 100(1):216-26. PubMed ID: 401484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Receptors and neurohormones in human pituitary adenomas.
    Peillon F; Le Dafniet M; Garnier P; Brandi AM; Moyse E; Birman P; Blumberg-Tick J; Grouselle D; Joubert-Bression D
    Horm Res; 1989; 31(1-2):13-8. PubMed ID: 2566572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different responses of growth hormone secretion to guanfacine, bromocriptine, and thyrotropin-releasing hormone in acromegalic patients with pure growth hormone (GH)-containing and mixed GH/prolactin-containing pituitary adenomas.
    Lamberts SW; Klijn JG; van Vroonhoven CC; Stefanko SZ
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1148-53. PubMed ID: 3923021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enzyme-immunoassay for estrogen receptors in human pituitary adenomas.
    Nakao H; Koga M; Arao M; Nakao M; Sato B; Kishimoto S; Saitoh Y; Arita N; Mori S
    Acta Endocrinol (Copenh); 1989 Feb; 120(2):233-8. PubMed ID: 2916384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Release of thyrotropin releasing hormone (TRH) from human prolactin-secreting pituitary adenoma cells. Modulation by dopamine].
    Le Dafniet M; Blumberg-Tick J; Yuan Li J; Brandi AM; Bression D; Barret A; Feinstein MC; Peillon F
    C R Acad Sci III; 1988; 306(3):129-34. PubMed ID: 3126991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Secretion of glycoprotein hormone alpha-subunit by pituitary tumors.
    Ishibashi M; Yamaji T; Takaku F; Teramoto A; Fukushima T
    J Clin Endocrinol Metab; 1987 Jun; 64(6):1187-93. PubMed ID: 2437140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pituitary adenomas of patients with acromegaly express thyrotropin-releasing hormone receptor messenger RNA: cloning and functional expression of the human thyrotropin-releasing hormone receptor gene.
    Yamada M; Monden T; Satoh T; Satoh N; Murakami M; Iriuchijima T; Kakegawa T; Mori M
    Biochem Biophys Res Commun; 1993 Sep; 195(2):737-45. PubMed ID: 8396925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prolactin response to thyrotropin-releasing hormone (TRH) in patients with hypothalamic-pituitary disease.
    Barbieri RL; Cooper DS; Daniels GH; Nathan D; Klibanski A; Ridgway EC
    Fertil Steril; 1985 Jan; 43(1):66-73. PubMed ID: 3917409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlative studies between the presence of thyrotropin-releasing hormone (TRH) receptors and the in vitro stimulation of growth-hormone (GH) secretion in human GH-secreting adenomas.
    Le Dafniet M; Garnier P; Bression D; Brandi AM; Racadot J; Peillon F
    Horm Metab Res; 1985 Sep; 17(9):476-9. PubMed ID: 2864309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure of the thyrotrophin-releasing hormone receptor in human pituitary adenomas.
    Faccenda E; Melmed S; Bevan JS; Eidne KA
    Clin Endocrinol (Oxf); 1996 Mar; 44(3):341-7. PubMed ID: 8729534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence of receptors for thyrotropin-releasing hormone in human prolactin-secreting adenomas.
    Le Dafniet M; Brandi AM; Bression D; Racadot T; Peillon F
    J Clin Endocrinol Metab; 1983 Aug; 57(2):425-7. PubMed ID: 6306043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitory effects of antivascular endothelial growth factor strategies in experimental dopamine-resistant prolactinomas.
    Luque GM; Perez-Millán MI; Ornstein AM; Cristina C; Becu-Villalobos D
    J Pharmacol Exp Ther; 2011 Jun; 337(3):766-74. PubMed ID: 21406548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison between the diagnostic value of gonadotropins, alpha-subunit, and chromogranin-A and their response to thyrotropin-releasing hormone in clinically nonfunctioning, alpha-subunit-secreting, and gonadotroph pituitary adenomas.
    Nobels FR; Kwekkeboom DJ; Coopmans W; Hoekstra R; De Herder WW; Bouillon R; Lamberts SW
    J Clin Endocrinol Metab; 1993 Sep; 77(3):784-9. PubMed ID: 7690365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prolactin secretion in mice with thyrotropin-releasing hormone deficiency.
    Yamada M; Shibusawa N; Ishii S; Horiguchi K; Umezawa R; Hashimoto K; Monden T; Satoh T; Hirato J; Mori M
    Endocrinology; 2006 May; 147(5):2591-6. PubMed ID: 16484326
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prolactin secretion from human prolactinomas perifused in vitro: effect of TRH, prostaglandin E1, theophylline, dopamine and dopamine receptor blockers.
    Chihara K; Iwasaki J; Minamitani N; Kaji H; Kodama H; Fujita T; Shirataki K; Tamaki N; Matsumoto S
    Acta Endocrinol (Copenh); 1984 Jan; 105(1):6-13. PubMed ID: 6421041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leukemia inhibitory factor regulates prolactin secretion in prolactinoma and lactotroph cells.
    Ben-Shlomo A; Miklovsky I; Ren SG; Yong WH; Heaney AP; Culler MD; Melmed S
    J Clin Endocrinol Metab; 2003 Feb; 88(2):858-63. PubMed ID: 12574225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endocrine and immunohistochemical studies on thyrotropin (TSH)-secreting pituitary adenomas: responses of TSH, alpha-subunit, and growth hormone to hypothalamic releasing hormones and their distribution in adenoma cells.
    Kuzuya N; Inoue K; Ishibashi M; Murayama Y; Koide Y; Ito K; Yamaji T; Yamashita K
    J Clin Endocrinol Metab; 1990 Nov; 71(5):1103-11. PubMed ID: 1699960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hormone secretion in vitro by plurihormonal pituitary adenomas of the acidophil cell line.
    Asa SL; Kovacs K; Horvath E; Singer W; Smyth HS
    J Clin Endocrinol Metab; 1992 Jul; 75(1):68-75. PubMed ID: 1352308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A giant prolactinoma and the effect of chronic bromocriptine therapy on basal and TRH-stimulated serum prolactin levels.
    Barrera CM; Ruiz AE; Banks WA
    Horm Res; 1991; 35(3-4):167-9. PubMed ID: 1806471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic value of thyrotropin-releasing-hormone stimulation in patients with pituitary tumor.
    Cook DM; Greer MA; Paxton H
    West J Med; 1987 Aug; 147(2):161-4. PubMed ID: 3116772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.